ProShare Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,786
| Closed | -$49.5K | – | 1960 |
|
|
2023
Q1 | $49.5K | Sell |
11,786
-1,099
| -9% | -$4.62K | ﹤0.01% | 1671 |
|
|
2022
Q4 | $77.4K | Buy |
12,885
+1,847
| +17% | +$11.1K | ﹤0.01% | 1694 |
|
|
2022
Q3 | $64K | Buy |
11,038
+633
| +6% | +$3.67K | ﹤0.01% | 1633 |
|
|
2022
Q2 | $62K | Buy |
+10,405
| New | +$62K | ﹤0.01% | 1677 |
|
|
2016
Q2 | – | Sell |
-2,824
| Closed | -$15K | – | 1656 |
|
|
2016
Q1 | $15K | Sell |
2,824
-255
| -8% | -$1.35K | ﹤0.01% | 1580 |
|
|
2015
Q4 | $38K | Buy |
3,079
+1,511
| +96% | +$18.6K | ﹤0.01% | 1684 |
|
|
2015
Q3 | $23K | Sell |
1,568
-508
| -24% | -$7.45K | ﹤0.01% | 1428 |
|
|
2015
Q2 | $40K | Sell |
2,076
-821
| -28% | -$15.8K | ﹤0.01% | 1617 |
|
|
2015
Q1 | $52K | Sell |
2,897
-323
| -10% | -$5.8K | ﹤0.01% | 1866 |
|
|
2014
Q4 | $76K | Sell |
3,220
-2,109
| -40% | -$49.8K | ﹤0.01% | 1882 |
|
|
2014
Q3 | $129K | Sell |
5,329
-1,208
| -18% | -$29.2K | ﹤0.01% | 2124 |
|
|
2014
Q2 | $184K | Sell |
6,537
-6,614
| -50% | -$186K | ﹤0.01% | 2208 |
|
|
2014
Q1 | $447K | Buy |
+13,151
| New | +$447K | 0.01% | 1954 |
|
|
2013
Q4 | – | Sell |
-7,115
| Closed | -$117K | – | 2481 |
|
|
2013
Q3 | $117K | Buy |
+7,115
| New | +$117K | ﹤0.01% | 2377 |
|